Physician profile
Rene Mosada
NPI 1013906759
$4,160.37
in general payments reported to CMS, 2019-2025
37 companies · $1,504 in 2025
The $1,504 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $99.98 · 2021: $163 · 2022: $349 · 2023: $634 · 2024: $1,254 · 2025: $1,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,236 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,236.13 |
| Education | $156.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $542.17 | 2021-2025 | |
| Eisai INC. | $386.43 | 2019-2025 | |
| Argenx US, INC. | $324.39 | 2023-2025 | Vyvgart Hytrulo |
| Novartis Pharmaceuticals Corporation | $297.64 | 2021-2025 | |
| Pfizer INC. | $222.92 | 2023-2025 | |
| Neurelis, INC. | $215.83 | 2020-2025 | Valtoco |
| Livanova USA, INC. | $201.70 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Grifols USA, LLC | $161.26 | 2023-2025 | Gamunex-C |
| Emd Serono, INC. | $152.24 | 2021-2023 | Mavenclad |
| Neurocrine Biosciences, INC. | $144.27 | 2023-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $142.25 | 2023-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Lundbeck LLC | $141.86 | 2020-2025 | Vyepti |
| Harmony Biosciences LLC | $127.63 | 2023-2024 | Wakix |
| Lilly USA, LLC | $120.48 | 2023-2025 | Kisunla, Emgality, Amyvid |
| Sk Life Science, INC. | $102.84 | 2024-2025 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Mosada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.